Wright Medical can submit more data to FDA for Augment bone graft

Wright Medical says it struck a deal with the FDA to submit more data on its Augment bone graft, previously deemed unapprovable by the watchdog agency.

Wright Medical (NSDQ:WMGI) said the FDA agreed to let it submit additional data for its pre-market approval application for the Augment bone graft it bought along with BioMimetic Therapeutics in 2012.

Wright Medical Group Inc., Food & Drug Administration (FDA)

News Well, Pre-Market Approval (PMA), Regulatory/Compliance, Resorbable bone materials

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1forDM0